Paul A Mahon, EVP & General Counsel at UNITED THERAPEUTICS, sold UTHR on Aug 20, 2026
Data as of Oct 16
- Traded
- Aug 20, 2026
- Disclosed
- Aug 21, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
+3.9%
after the sale
Similar stocks (XLV) since disclosure
+1.2%
XLV — its sector index fund
Change in closing price from Aug 21, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$411Kdisclosed Aug 21 · filed 1 day after the trade
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$261Kdisclosed Aug 21 · filed 1 day after the trade
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$211Kdisclosed Aug 21 · filed 1 day after the trade
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$494Kdisclosed Aug 21 · filed 1 day after the trade
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$948Kdisclosed Aug 21 · filed 1 day after the trade
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$63.3Kdisclosed Aug 21 · filed 1 day after the trade
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$101Kdisclosed Aug 21 · filed 1 day after the trade
- ▼ SELLPaul A Mahon EVP & General CounselUTHR UNITED THERAPEUTICS Corp$444Kdisclosed Aug 21 · filed 1 day after the trade